Generics News
-
Lupin launches Tadalafil Tablets
Generics | News | 0 Comment | 13 Feb, 2019
Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United State...Read more
-
Lupin receives FDA approval for Fluoxetine Tablets
Generics | News | 0 Comment | 13 Feb, 2019
Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States ...Read more
-
Lupin announces launch of NaMuscla
Generics | News | 0 Comment | 04 Feb, 2019
India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdo...Read more
-
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval
Generics | News | 0 Comment | 01 Feb, 2019
Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmetero...Read more
-
Cipla receives approval for Pfizer’s Depo-Provera
Generics | News | 0 Comment | 28 Jan, 2019
Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application ...Read more
-
Glenmark receives tentative ANDA approval for Topiramate
Generics | News | 0 Comment | 24 Jan, 2019
Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (...Read more
-
Lupin receives FDA approval for Levothyroxine Sodium Tablets
Generics | News | 0 Comment | 22 Jan, 2019
Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 m...Read more
-
J&J completes acquisition of Ci:z Holdings
Generics | News | 0 Comment | 18 Jan, 2019
Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...Read more
-
Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma
Generics | News | 0 Comment | 18 Jan, 2019
Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology inject...Read more
-
Lupin’s NaMuscla receives EC Approval
Generics | News | 0 Comment | 08 Jan, 2019
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...Read more
-
Hetero Labs limited acquires Tarbis Farma
Generics | News | 0 Comment | 02 Jan, 2019
Telangana based Pharma company, Hetero has announced that its European subsidiary Amarox Limited has acquired Tarbis Far...Read more
-
JHL Biotech declares Phase III Study of JHL1101
Generics | News | 0 Comment | 28 Dec, 2018
JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...Read more
-
Dr. Reddy's lab announces the launch of Sevelamer Carbonate in US
Generics | News | 0 Comment | 28 Dec, 2018
Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...Read more
-
Dr. Reddy's launches Aspirin and Extended-Release Dipyridamole Capsules in USA
Generics | News | 0 Comment | 27 Dec, 2018
Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivale...Read more
-
Generics | Opinion | By Priyanka Bajpai | 0 Comment | 17 Dec, 2018
Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...Read more
-
Dr. Reddy’s announces the launch of Omeprazole Delayed-Release Tablets
Generics | News | 2 Comment | 11 Dec, 2018
Dr. Reddy’s has announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store...Read more
-
Amgen's Repatha shows durable treatment effect in long-term study
Generics | News | 0 Comment | 13 Nov, 2018
Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...Read more
-
FDA approves first generic version of EpiPen
Generics | News | 1 Comment | 17 Aug, 2018
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...Read more
